Search the Newsreel

Kenvue options activity surges on bullish call bets ahead of merger news

Kenvue Inc. (KVUE) is experiencing a surge in bullish call options activity, with over 12,000 contracts traded, indicating traders anticipate a significant upward price movement. The high concentration of calls at the $19.50 strike price, expiring soon, alongside a spike in volatility, suggests market …

San Luis Wealth Advisors LLC Buys New Stake in Kenvue Inc. $KVUE

San Luis Wealth Advisors LLC recently acquired a new stake in Kenvue Inc. (NYSE:KVUE), purchasing 52,880 shares valued at approximately $1.01 million. Kenvue's stock is largely held by institutional investors, owning 97.64% of the company, and analysts generally rate it as a "Hold" with …

Handelsbanken Fonder AB Has $21.75 Million Position in Kenvue Inc. $KVUE

Handelsbanken Fonder AB increased its stake in Kenvue Inc. (NYSE:KVUE) by 6.5% during the second quarter, bringing its total holdings to over 1.1 million shares valued at approximately $21.75 million. Other institutional investors also adjusted their positions in Kenvue, with notable increases from firms …

Medical Properties Trust (MPT) As Refinancing And Earnings Progress Feed The Undervalued View

Brookstone Capital Management Sells 193,541 Shares of Kenvue Inc. $KVUE

Brookstone Capital Management significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 70.3% in the second quarter, selling 193,541 shares and retaining 81,929 shares valued at $1.57 million. This divestment occurred as Kenvue reported slightly lower-than-expected quarterly EPS of $0.31, missing the $0.32 consensus, …

Kenvue Stock And 2 Consumer Staples Picks For Defensive Dividend Investors

Form 8K ENvue Medical Inc For: 12 August By Investing.com

This article reports that ENvue Medical Inc. filed a Form 8K on August 12. The brief announcement provides no further details regarding the content of the filing. It is published by Investing.com.

FEED Looks 91.4% Undervalued on GF Value™ Despite Distressed Fundamentals

ENvue Medical Inc (NASDAQ: FEED) announced a $50 million equity facility to enhance its ENvue feeding tube navigation system and explore new technologies, despite a nearly 10% pre-market share drop. The company's GF Value™ suggests it is 91.4% undervalued, yet its GF Score™ of …

12 Health Care Stocks Moving In Wednesday's After-Market Session

This article details the performance of 12 healthcare stocks during Wednesday's after-market session, categorized into gainers and losers. Notable gainers include ENvue Medical and Omeros, with Omeros reporting Q2 earnings. Significant losers include Outlook Therapeutics and Valion Bio.

Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects

Kenvue Inc. KVUE, the world's leading pure-play consumer health company, delivered year-over-year improvement in second-quarter 2026, although earnings and sales slightly missed the respective Zacks Consensus Estimate. Net sales rose 3% year over year to $3.96 billion, while organic sales increased 1.6%. Kenvue's second-quarter …

ENvue Medical secures $50M equity financing facility By Investing.com

ENvue Medical, Inc. has announced a securities purchase agreement with an institutional investor for an equity financing facility of up to $50 million, subject to stockholder approval. The medical technology company plans to use the capital to advance its technology platform, accelerate the adoption …

ENvue Medical secures up to $50M equity facility to fund growth plans

* ENvue Medical (FEED [https://seekingalpha.com/symbol/FEED]) said on Wednesday that it entered into a securities purchase agreement [https://seekingalpha.com/pr/20616538-envue-medical-secures-equity-financing-facility-of-up-to-50-million-to-support-commercial] with an institutional investor for an equity facility of up to $50M, subject to stockholder approval. * The funding will support the expansion of its ENvue feeding …

ENVUE Medical (FEED) adds $50M equity facility and boosts $59M Series H rights

ENVUE Medical (FEED) has secured a new committed equity facility of up to $50 million with an institutional investor, allowing the company to sell common shares at its discretion, with 40% of net proceeds earmarked for Series X Preferred Stock redemption. Additionally, the company …

ENvue Medical Secures $50 Million Equity Facility; Expands Series H Investment Rights to $59 Million

ENvue Medical has secured a $50 million committed equity facility with an institutional investor and increased its Series H preferred financing Additional Investment Rights to $59 million. The equity facility allows ENvue to sell common shares at 90% of the lowest VWAP over three …

ENvue Medical Eyes AI, Automation, Acquisitions With Up to $50M

ENvue Medical (NASDAQ: FEED) has secured an equity financing facility of up to $50 million, pending stockholder approval, to boost its financial flexibility. The capital is intended to advance its next-generation medical technology platform, including AI and automation technologies, and to fund strategic acquisitions. …

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

ENvue Medical, Inc. announced a securities purchase agreement with an institutional investor for an equity facility of up to $50 million, pending stockholder approval. This financing aims to enhance ENvue's financial flexibility, advance its next-generation technology, and support strategic acquisitions and business development. The …

RBC Capital Sticks to Its Hold Rating for Kenvue, Inc. (KVUE)

RBC Capital maintained its Hold rating on Kenvue, Inc. (KVUE) with a $20.00 price target, while Canaccord Genuity also kept a Hold rating with an $18.00 target. Kenvue recently reported increased quarterly revenue and net profit. Insider sentiment for KVUE stock is negative, with …

ENvue Medical Ord Shs (FEED) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for ENvue Medical Ord Shs (FEED), detailing its stock performance, market capitalization, and a comparison with peer companies. The financial forecasting includes expected EPS, revenue, net profit, and EBIT. It highlights that the data was updated on August …

KVUE Maintained by UBS -- Price Target Lowered to $19.00

UBS has lowered its price target for Kenvue Inc (KVUE) from $20.00 to $19.00 while maintaining a Neutral rating. Despite this, GuruFocus calculates KVUE's GF Value™ at $19.70, suggesting the stock is currently undervalued by 3.3%. The company, a consumer health leader with brands …

UBS Adjusts Kenvue Price Target to $19 From $20, Maintains Neutral Rating

UBS has adjusted its price target for Kenvue (KVUE) to $19 from $20, while maintaining a Neutral rating on the stock. This adjustment comes shortly after HSBC also revised its price target for Kenvue to $19 from $20, maintaining a Hold rating. The article …

ENvue Medical (FEED) seeks up to $50M via shelf for stock, warrants, units

ENvue Medical (FEED) has filed a shelf registration to offer up to $50 million in common stock, warrants, and units, which may be sold over time. The company's common stock trades on Nasdaq under the symbol FEED, with a recent price of $0.40 per …

Kenvue Inc (KVUE) Stock News Today

This article provides Kenvue Inc (KVUE) stock news, including its current stock price, market capitalization, and P/E ratio. It highlights the company's recent Q2 2026 earnings report, which showed increased sales and EPS despite narrowing margins. The page also offers various financial data, analyst …

Kenvue Inc. Stock 12‑Month Price Target Cut to $19.4, Implies 1% Upside

Kenvue Inc.'s average 12-month price target has been lowered from $19.5 to $19.4 by 10 analysts, with forecasts ranging from $18 to $22 per share. This updated target suggests a 1% potential upside from its August 7 closing price. The consensus rating for Kenvue …

HSBC Adjusts Price Target on Kenvue to $19 From $20, Maintains Hold Rating

HSBC has revised its price target for Kenvue (KVUE) to $19, down from the previous $20, while reaffirming a Hold rating on the stock. This adjustment comes amidst recent news including Kenvue's Q2 adjusted earnings and revenue rising, as well as the company missing …

Kenvue Q2: Skin Health & Beauty Net Sales Rise 5.1%

Kenvue reported strong Q2 2026 results with overall net sales up 3.0% and organic sales up 1.6%. The Skin Health & Beauty segment was a key driver, seeing a 5.1% increase in net sales, attributed to strong e-commerce performance, strategic execution, and innovations. The …

Jacobs & Co. CA Has $1.83 Million Stake in Kenvue Inc. $KVUE

Jacobs & Co. CA significantly reduced its stake in Kenvue Inc. by 45.7% in the second quarter, now holding 96,044 shares valued at $1.83 million. Despite missing analyst expectations for Q2 adjusted EPS and revenue, Kenvue's revenue increased by 3.0% year over year, and …

Enterprise value to EBITDA forward of ENvue Medical, Inc. – NASDAQ:FEED

This article focuses on the enterprise value to EBITDA forward for ENvue Medical, Inc. (NASDAQ: FEED). It appears to be a financial data point presented within a TradingView context, indicating financial analysis for the company. The content primarily highlights the metric within the platform, …

Wall Street Zen Downgrades Kenvue (NYSE:KVUE) to Hold

Wall Street Zen has downgraded Kenvue (NYSE:KVUE) from a "Buy" to a "Hold" rating, reflecting a consensus among analysts. The company's second-quarter revenue grew 3% year-over-year to $3.96 billion, but EPS and revenue slightly missed expectations due to inflationary pressures, tariffs, and currency costs. …

Kenvue Inc. $KVUE Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 49.8% in the second quarter, selling 3.19 million shares and retaining 3.22 million shares. This move comes as Kenvue reported Q2 sales of $3.96 billion and adjusted EPS of $0.31, both …

Kenvue (KVUE) Stock Holds Firm As Margin Gains Anchor The Story

Noticias de acciones de Kenvue Inc (KVUE)

Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Kenvue (KVUE) reported Q2 earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32, though it represents an increase from $0.29 per share a year ago. The company also missed revenue estimates, posting $3.96 billion against an expected $3.99 billion. Despite these …

Kenvue Earnings: Rare Volume Growth Despite Muted US and Europe Performance Impresses

Kenvue reported 3% revenue growth and 7% adjusted EPS growth in the second quarter, driven by 0.7% volume growth despite muted performance in the US and Europe. This volume growth was a rare achievement for the company. Morningstar highlighted this positive performance in their …